Agreed. And that clinical validation had been missing previously.
The significance is Macular's formula is the first to receive clinical validation that it does indeed slow the onset of age related macular degeneration.
Its proven - it will be prescribed/recommended. I think Fuse is riding the coat tails of Macular's success in that some/all of Macular's products for this will feature the DROP technology from Fuse.